Developer docs
API playgroundTry for free, no card

Search company profiles

Techdow USA

Full company profile

uuid003i6lw

Namestring
Techdow USA
Legal namestring
Techdow USA Inc.
Websiteurl
techdowusa.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Techdow USA Inc. is a US-based, privately held pharmaceutical company headquartered at 2050 Cabot Boulevard West, Suite 200 in Langhorne, Pennsylvania. It develops, manufactures, and sells FDA-approved critical-care injectable medications for hospital, clinical, and dialysis-center settings. Its portfolio consists of three core product lines: Heparin Sodium Injection USP (an anticoagulant offered across nine vial presentations from 1,000 to 50,000 USP Units/mL, with the 30,000 USP Units/30mL vial noted as the most widely used SKU for dialysis centers); Enoxaparin Sodium, a preservative-free generic version of Lovenox® delivered in prefilled syringes across seven dosage strengths (30mg to 150mg); and Fosaprepitant Injection USP (150mg lyophilized vials), an antiemetic for chemotherapy-induced nausea and vomiting launched in collaboration with CTTQ Pharma in August 2023. The company emphasizes vertical integration in raw materials as the basis for competitive pricing and supply reliability, including a direct-purchase contingency channel introduced during the 2022 heparin shortage.

The company operates a sales-led go-to-market model targeting hospital pharmacy buyers and dialysis operators through a customer operations team and a purchasing portal hosted by R&S Solutions. Its Business Development organization is described as a global group of experts, and commercial reach is reinforced by active participation in ASHP, CPHI, DCAT, NACDS, NPPA, IDN Summits, and other major industry events. Marketing is concentrated in earned media (Business Wire press releases, Fierce Pharma sponsored content) and a corporate website that surfaces product information, partnership opportunities, and adverse-event reporting. Techdow USA is a subsidiary operating within the Hepalink network (referenced alongside 'Hepalink USA, Inc.' in adverse-event reporting), with Hepalink acting as a strategic parent and a global leader in pharmaceutical heparin API. The company holds NABP Accredited Drug Distributor status and reports no AI, software, or platform products.

Short descriptiontext

Techdow USA is a private, FDA-approved pharmaceutical company in Langhorne, Pennsylvania that manufactures and sells critical-care injectable medications — Heparin Sodium, generic Enoxaparin (Lovenox®), and Fosaprepitant — to US hospitals, clinical settings, and dialysis centers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLanghorne, United States
HQ citystring
Langhorne
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic injectables, anticoagulant manufacturing, hospital pharmaceuticals, heparin sodium production, enoxaparin prefilled syringes
Industry1 code
PRIMARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
Product category
Generic Injectable Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Techdow USA generates revenue through the development, manufacture, and sale of FDA approved critical pharmaceutical products. Their product portfolio includes Heparin Sodium Injection (multiple strengths), Enoxaparin Sodium Prefilled Syringes, and Fosaprepitant Injection. Products are sold to hospital and clinical settings including dialysis centers. The company is vertically integrated in raw materials, enabling competitive pricing and reliable supply.

techdowusa.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Techdow USA develops, manufactures, and sells FDA-approved critical injectable pharmaceuticals for hospital and clinical settings. Its product portfolio consists of Heparin Sodium Injection USP (multiple strengths/vials), Enoxaparin Sodium prefilled syringes (generic Lovenox), and Fosaprepitant Injection (antiemetic). The company is vertically integrated in raw materials, enabling it to deliver hard-to-source products at competitive prices and offer special-access supply during shortages.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Successfully launched FDA approved generic Enoxaparin Sodium (Lovenox) in prefilled syringes, March 2023
+1 more record
Product overview1 text field

Techdow USA is a vertically integrated pharmaceutical company that develops, manufactures, and sells FDA-approved critical-care medications for hospital and clinical settings. The company's product portfolio consists of three core product lines: Heparin Sodium Injection, USP (a widely-used anticoagulant with nine strength variants ranging from 1,000 to 50,000 USP Units/mL in various vial sizes); Enoxaparin Sodium (a generic version of Lovenox® delivered as preservative-free prefilled syringes in seven dosage strengths from 30mg to 150mg); and Fosaprepitant Injection, USP (an antiemetic for chemotherapy-induced nausea launched via collaboration with CTTQ Pharma). The company emphasizes its vertically integrated raw materials capabilities that enable competitive pricing and reliable supply, including special access options during critical market shortages.

Product and service3 records
1Heparin Sodium Injection, USP
CategoryAnticoagulant injectables
Description

FDA-approved anticoagulant medication available in multiple strengths (1,000 to 50,000 USP Units/mL) across nine SKU/vial formats for hospital and clinical settings. Includes 5,000 USP Units/1mL, 2,000 USP Units/2mL, 10,000 USP Units/10mL, 1,000 USP Units/1mL, 20,000 USP Units/1mL, 30,000 USP Units/30mL (most widely used for dialysis centers), 50,000 USP Units/5mL, and 50,000 USP Units/10mL presentations.

2Enoxaparin Sodium (Generic Lovenox) Prefilled Syringes
CategoryAnticoagulant injectables
Description

FDA-approved generic version of Lovenox (Enoxaparin Sodium – Preservative Free) delivered as prefilled syringes in seven dosage strengths (30mg to 150mg) for anticoagulation therapy in hospital and clinical settings.

3Fosaprepitant Injection, USP
CategoryAntiemetic injectables
Description

FDA-approved injectable antiemetic medication for prevention of chemotherapy-induced nausea and vomiting. Available as 150mg lyophilized vials, launched in collaboration with CTTQ Pharma for hospital and clinical use.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1CTTQ Pharma
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-08-22
Description

Techdow USA and CTTQ Pharma announced a collaboration agreement and launched Fosaprepitant for Injection. This partnership enables Techdow USA to expand its product portfolio with an additional specialty pharmaceutical product for hospital use.

techdowusa.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Meitheal is a smaller, growth-oriented US generic injectables company focused on critical-care and oncology-support sterile products for hospital customers, directly comparable to Techdow USA's positioning and channel strategy.

2Sandoz
TypeBroad incumbent
Description

Sandoz is the world's largest generics company by revenue and is the originator's authorized enoxaparin competitor, with broad US hospital injectable coverage. It is a broader incumbent versus Techdow USA's niche focus, but a direct head-to-head on enoxaparin.

TypeDirect peer
Description

Amphastar is a specialty generic injectable manufacturer with leading positions in enoxaparin sodium (generic Lovenox), heparin sodium, and other critical-care injectables. It is the most direct US competitor to Techdow USA across the same hospital/clinical channels and product categories.

TypeDirect peer
Description

Fresenius Kabi is a global supplier of generic injectable pharmaceuticals, including heparin and enoxaparin products sold to US hospitals. It competes head-to-head with Techdow USA in sterile hospital injectables and shares the same vertically-integrated supplier profile.

TypeBroad incumbent
Description

Baxter supplies a broad range of sterile injectable and hospital products globally, including heparin. As a larger incumbent with diversified offerings, it overlaps with Techdow USA in critical-care injectables while serving many other hospital categories.

TypeDirect peer
Description

ANI is a US specialty generics company focused on hospital and institutional injectable products, including anticoagulants and limited-competition sterile injectables. It is a similarly-sized, similarly-focused direct competitor.

TypeDirect peer
Description

Hikma is a leading US supplier of generic injectable medicines (heparin, oncology injectables, anaesthesia) with a direct hospital sales model that mirrors Techdow USA's channel strategy and target buyer profile.

TypeBroad incumbent
Description

Teva is a major US generics supplier with an injectable portfolio that includes anticoagulants; it competes with Techdow USA in critical-care hospital injectables while operating across many more therapeutic areas.

TypeDirect peer
Description

Dr. Reddy's is a vertically integrated generic injectables player selling into US hospitals, with strong positions in oncology-support injectables and other sterile hospital products comparable to Techdow USA's portfolio.

TypeBroad incumbent
Description

Pfizer's Hospital business (built on the acquired Hospira franchise) is one of the largest US injectable suppliers, including heparin and enoxaparin. As a broad incumbent it competes across Techdow USA's full portfolio in hospitals and dialysis.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Techdow USA

Generic Injectable Pharmaceuticalstechdowusa.com

Techdow USA is a private, FDA-approved pharmaceutical company in Langhorne, Pennsylvania that manufactures and sells critical-care injectable medications — Heparin Sodium, generic Enoxaparin (Lovenox®), and Fosaprepitant — to US hospitals, clinical settings, and dialysis centers.

What Techdow USA does

Techdow USA Inc. is a US-based, privately held pharmaceutical company headquartered at 2050 Cabot Boulevard West, Suite 200 in Langhorne, Pennsylvania. It develops, manufactures, and sells FDA-approved critical-care injectable medications for hospital, clinical, and dialysis-center settings. Its portfolio consists of three core product lines: Heparin Sodium Injection USP (an anticoagulant offered across nine vial presentations from 1,000 to 50,000 USP Units/mL, with the 30,000 USP Units/30mL vial noted as the most widely used SKU for dialysis centers); Enoxaparin Sodium, a preservative-free generic version of Lovenox® delivered in prefilled syringes across seven dosage strengths (30mg to 150mg); and Fosaprepitant Injection USP (150mg lyophilized vials), an antiemetic for chemotherapy-induced nausea and vomiting launched in collaboration with CTTQ Pharma in August 2023. The company emphasizes vertical integration in raw materials as the basis for competitive pricing and supply reliability, including a direct-purchase contingency channel introduced during the 2022 heparin shortage.

The company operates a sales-led go-to-market model targeting hospital pharmacy buyers and dialysis operators through a customer operations team and a purchasing portal hosted by R&S Solutions. Its Business Development organization is described as a global group of experts, and commercial reach is reinforced by active participation in ASHP, CPHI, DCAT, NACDS, NPPA, IDN Summits, and other major industry events. Marketing is concentrated in earned media (Business Wire press releases, Fierce Pharma sponsored content) and a corporate website that surfaces product information, partnership opportunities, and adverse-event reporting. Techdow USA is a subsidiary operating within the Hepalink network (referenced alongside 'Hepalink USA, Inc.' in adverse-event reporting), with Hepalink acting as a strategic parent and a global leader in pharmaceutical heparin API. The company holds NABP Accredited Drug Distributor status and reports no AI, software, or platform products.

Techdow USA firmographics

Firmographics
Name
Techdow USA
Legal name
Techdow USA Inc.
Website
https://techdowusa.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Techdow USA is a private, FDA-approved pharmaceutical company in Langhorne, Pennsylvania that manufactures and sells critical-care injectable medications — Heparin Sodium, generic Enoxaparin (Lovenox®), and Fosaprepitant — to US hospitals, clinical settings, and dialysis centers.
Ownership category
akta.pro rank

Techdow USA industry classification

Industry
Product category
Generic Injectable Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
akta.pro industry
PRIMARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing

Keywords

  • Generic injectables
  • Anticoagulant manufacturing
  • Hospital pharmaceuticals
  • Heparin sodium production
  • Enoxaparin prefilled syringes

Where Techdow USA is headquartered

Location

Headquarters

HQ city
Langhorne
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Techdow USA business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Product Sales: Techdow USA generates revenue through the development, manufacture, and sale of FDA approved critical pharmaceutical products. Their product portfolio includes Heparin Sodium Injection (multiple strengths), Enoxaparin Sodium Prefilled Syringes, and Fosaprepitant Injection. Products are sold to hospital and clinical settings including dialysis centers. The company is vertically integrated in raw materials, enabling competitive pricing and reliable supply.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Techdow USA product offering

Product offering

Core offering

Techdow USA develops, manufactures, and sells FDA-approved critical injectable pharmaceuticals for hospital and clinical settings. Its product portfolio consists of Heparin Sodium Injection USP (multiple strengths/vials), Enoxaparin Sodium prefilled syringes (generic Lovenox), and Fosaprepitant Injection (antiemetic). The company is vertically integrated in raw materials, enabling it to deliver hard-to-source products at competitive prices and offer special-access supply during shortages.

Product overview

Techdow USA is a vertically integrated pharmaceutical company that develops, manufactures, and sells FDA-approved critical-care medications for hospital and clinical settings. The company's product portfolio consists of three core product lines: Heparin Sodium Injection, USP (a widely-used anticoagulant with nine strength variants ranging from 1,000 to 50,000 USP Units/mL in various vial sizes); Enoxaparin Sodium (a generic version of Lovenox® delivered as preservative-free prefilled syringes in seven dosage strengths from 30mg to 150mg); and Fosaprepitant Injection, USP (an antiemetic for chemotherapy-induced nausea launched via collaboration with CTTQ Pharma). The company emphasizes its vertically integrated raw materials capabilities that enable competitive pricing and reliable supply, including special access options during critical market shortages.

Differentiator

Problem solved

Functional benefit

Products and services

  • Heparin Sodium Injection, USP FDA-approved anticoagulant medication available in multiple strengths (1,000 to 50,000 USP Units/mL) across nine SKU/vial formats for hospital and clinical settings. Includes 5,000 USP Units/1mL, 2,000 USP Units/2mL, 10,000 USP Units/10mL, 1,000 USP Units/1mL, 20,000 USP Units/1mL, 30,000 USP Units/30mL (most widely used for dialysis centers), 50,000 USP Units/5mL, and 50,000 USP Units/10mL presentations.
  • Enoxaparin Sodium (Generic Lovenox) Prefilled Syringes FDA-approved generic version of Lovenox (Enoxaparin Sodium – Preservative Free) delivered as prefilled syringes in seven dosage strengths (30mg to 150mg) for anticoagulation therapy in hospital and clinical settings.
  • Fosaprepitant Injection, USP FDA-approved injectable antiemetic medication for prevention of chemotherapy-induced nausea and vomiting. Available as 150mg lyophilized vials, launched in collaboration with CTTQ Pharma for hospital and clinical use.

Quantifiable outcome

  • Successfully launched FDA approved generic Enoxaparin Sodium (Lovenox) in prefilled syringes, March 2023
  • +1 more outcomes

Companies that use Techdow USA

Customer profile

Segments2 records

Ideal customer profiles1 record

Techdow USA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Techdow USA partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CTTQ PharmacoreStrategic or Co-development Partner · 22 August 2023Techdow USA and CTTQ Pharma announced a collaboration agreement and launched Fosaprepitant for Injection. This partnership enables Techdow USA to expand its product portfolio with an additional specialty pharmaceutical product for hospital use.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Techdow USA competitors and assessment

Company assessment

Direct peers

  • Meitheal Pharmaceuticals: Meitheal is a smaller, growth-oriented US generic injectables company focused on critical-care and oncology-support sterile products for hospital customers, directly comparable to Techdow USA's positioning and channel strategy.
  • Amphastar Pharmaceuticals: Amphastar is a specialty generic injectable manufacturer with leading positions in enoxaparin sodium (generic Lovenox), heparin sodium, and other critical-care injectables. It is the most direct US competitor to Techdow USA across the same hospital/clinical channels and product categories.
  • Fresenius Kabi: Fresenius Kabi is a global supplier of generic injectable pharmaceuticals, including heparin and enoxaparin products sold to US hospitals. It competes head-to-head with Techdow USA in sterile hospital injectables and shares the same vertically-integrated supplier profile.
  • ANI Pharmaceuticals: ANI is a US specialty generics company focused on hospital and institutional injectable products, including anticoagulants and limited-competition sterile injectables. It is a similarly-sized, similarly-focused direct competitor.
  • Hikma Pharmaceuticals: Hikma is a leading US supplier of generic injectable medicines (heparin, oncology injectables, anaesthesia) with a direct hospital sales model that mirrors Techdow USA's channel strategy and target buyer profile.
  • Dr. Reddy's Laboratories: Dr. Reddy's is a vertically integrated generic injectables player selling into US hospitals, with strong positions in oncology-support injectables and other sterile hospital products comparable to Techdow USA's portfolio.

Broad incumbents

  • Sandoz: Sandoz is the world's largest generics company by revenue and is the originator's authorized enoxaparin competitor, with broad US hospital injectable coverage. It is a broader incumbent versus Techdow USA's niche focus, but a direct head-to-head on enoxaparin.
  • Baxter International: Baxter supplies a broad range of sterile injectable and hospital products globally, including heparin. As a larger incumbent with diversified offerings, it overlaps with Techdow USA in critical-care injectables while serving many other hospital categories.
  • Teva Pharmaceutical Industries: Teva is a major US generics supplier with an injectable portfolio that includes anticoagulants; it competes with Techdow USA in critical-care hospital injectables while operating across many more therapeutic areas.
  • Pfizer (Hospira Injectables): Pfizer's Hospital business (built on the acquired Hospira franchise) is one of the largest US injectable suppliers, including heparin and enoxaparin. As a broad incumbent it competes across Techdow USA's full portfolio in hospitals and dialysis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Techdow USA social profiles

Digital presence

Techdow USA compliance and trust

Trust signal

Compliance2 records

Techdow USA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Techdow USA leadership team

Management profile

Number of profiles

Techdow USA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Techdow USA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Techdow USA

What does Techdow USA do?

Techdow USA develops, manufactures, and sells FDA-approved critical injectable pharmaceuticals for hospital and clinical settings. Its product portfolio consists of Heparin Sodium Injection USP (multiple strengths/vials), Enoxaparin Sodium prefilled syringes (generic Lovenox), and Fosaprepitant Injection (antiemetic). The company is vertically integrated in raw materials, enabling it to deliver hard-to-source products at competitive prices and offer special-access supply during shortages.

Is Techdow USA a public or private company?

Techdow USA is a private company. It is classified as corporate owned and is currently operating.

When was Techdow USA founded?

Techdow USA was founded in -1. It employs 1 to 10 people.

Where is Techdow USA based?

Techdow USA is headquartered in Langhorne, United States, in the North America region.

How does Techdow USA make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Techdow USA's main competitors?

Direct peers on record are Meitheal Pharmaceuticals, Amphastar Pharmaceuticals, Fresenius Kabi, ANI Pharmaceuticals, Hikma Pharmaceuticals and Dr. Reddy's Laboratories. Broad incumbents are Sandoz, Baxter International, Teva Pharmaceutical Industries and Pfizer (Hospira Injectables).

Does Techdow USA have an API?

No public API is recorded for Techdow USA.

What industry is Techdow USA in?

Techdow USA's product category is Generic Injectable Pharmaceuticals. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing. Its NAICS code is 325412.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales